Although rapamycin, a well-known immunosuppressive drug and commonly used anti-cancer treatment, inhibits mTOR and is an inducer of autophagy, it would have limited utility in TB due to its variable oral absorption and metabolism by CYP3A4, which is induced by the anti-TB drug rifampin (13). Here, MTOR is linked to tuberculosis.